Clinical case of simultaneous robot-assisted low anterior resection with radical prostatectomy and bilateral pelvic lymph node dissection

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Treatment of synchronous multiple primary rectal and prostate cancer is not standardized. Simultaneous surgery is not widespread. However, more and more reports are appearing in the world literature on the performance of simultaneous operations using robotic platforms.

We present a description of surgical treatment of a 64-year-old patient with synchronous primary rectal and prostate cancer. A robotic-assisted low anterior rectal resection with D3 lymph node dissection, combined with radical prostatectomy and bilateral lymph node dissection was performed. The duration of surgery was 610 minutes with a blood loss of 500 ml. A lymphocele developed in the left lateral lymph node dissection area, requiring ultrasound-guided drainage. Morphological examination revealed negative resection margins for both tumors. No metastatic cells in the pelvic lymph nodes were detected. Adjuvant chemotherapy for rectal cancer was conducted. No signs of rectal or prostate cancer recurrence were observed in 12 months after surgery. Continuity of the colon was restored.

Simultaneous robotic surgery may be considered as a treatment option for synchronous rectal and prostate cancer in a limited group of patients.

About the authors

I. S. Ignatov

Clinic of Proctology and Minimally Invasive Surgery of I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Author for correspondence.
Email: ignatov.mac93@mail.ru
ORCID iD: 0000-0002-8550-1909
Russian Federation, Build. 1, 1 Pogodinskaya St., Moscow, 119435

A. A. Derinov

Clinic of Proctology and Minimally Invasive Surgery of I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: ignatov.mac93@mail.ru
ORCID iD: 0000-0001-9449-5945
Russian Federation, Build. 1, 1 Pogodinskaya St., Moscow, 119435

V. V. Balaban

Clinic of Proctology and Minimally Invasive Surgery of I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: ignatov.mac93@mail.ru
ORCID iD: 0000-0002-7226-4641
Russian Federation, Build. 1, 1 Pogodinskaya St., Moscow, 119435

E. A. Bezrukov

Clinic of Proctology and Minimally Invasive Surgery of I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: ignatov.mac93@mail.ru
ORCID iD: 0000-0002-2746-5962
Russian Federation, Build. 1, 1 Pogodinskaya St., Moscow, 119435

N. N. Muradova

Clinic of Proctology and Minimally Invasive Surgery of I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: ignatov.mac93@mail.ru
ORCID iD: 0000-0003-2537-0705
Russian Federation, Build. 1, 1 Pogodinskaya St., Moscow, 119435

P. A. Volkova

Clinic of Proctology and Minimally Invasive Surgery of I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: ignatov.mac93@mail.ru
ORCID iD: 0009-0001-1589-7020
Russian Federation, Build. 1, 1 Pogodinskaya St., Moscow, 119435

A. K. Yaylakhanyan

Clinic of Proctology and Minimally Invasive Surgery of I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: ignatov.mac93@mail.ru
ORCID iD: 0009-0003-2699-0073
Russian Federation, Build. 1, 1 Pogodinskaya St., Moscow, 119435

P. V. Tsarkov

Clinic of Proctology and Minimally Invasive Surgery of I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: ignatov.mac93@mail.ru
ORCID iD: 0000-0002-7134-6821
Russian Federation, Build. 1, 1 Pogodinskaya St., Moscow, 119435

References

  1. Williams M., Perera M., Nouhaud F.X. et al. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy. Investig Clin Urol 2021;62(1):111–20. doi: 10.4111/icu.20200176
  2. Fukata K., Akiyoshi T., Fukunaga Y. et al. Robotic-assisted laparoscopic surgery for synchronous primary rectal and prostate cancer: initial case series. Asian J Endosc Surg 2022;15(3):678–82. doi: 10.1111/ases.13048
  3. Nassar A., Aly N.E., Elhusseini M. et al. Outcomes of the management of synchronous rectal and prostate cancer: a systematic review. Int J Colorectal Dis 2025;40(1):195. doi: 10.1007/s00384-025-04992-w
  4. Imagami T., Takayama S., Hattori T. et al. Combined laparoscopic and robotic surgery for synchronous colorectal and genitourinary cancer: a case series. Int J Surg Case Rep 2018;51:323–7. doi: 10.1016/j.ijscr.2018.09.021
  5. Bray F., Ferlay J., Soerjomataram I. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6): 394–424. doi: 10.3322/caac.21492
  6. Sidiqi B.U., Nosrati J.D., Wu J. et al. The prevalence and management of synchronous prostate and rectal cancer. Int J Radiat Oncol Biol Phys 2023;117(2):e339. doi: 10.1016/j.ijrobp.2023.06.2398
  7. Lee H.J., Lee A., Huang H.H. et al. Primary androgen deprivation therapy as monotherapy in unfavourable intermediate- and high-risk localised prostate cancer: a Singaporean single-centre perspective. Int Urol Nephrol 2018;50(4):665–73. doi: 10.1007/s11255-018-1802-4
  8. Widmark A., Klepp O., Solberg A. et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009;373(9660):301–8. doi: 10.1016/S0140-6736(08)61815-2
  9. Horwitz E.M., Bae K., Hanks G.E. et al. Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer. J Clin Oncol 2008;26(15):2497–504. doi: 10.1200/JCO.2007.14.9021
  10. Wallis C.J.D., Saskin R., Choo R. et al. Surgery versus radiotherapy for clinically-localized prostate cancer: a systematic review and meta-analysis. Eur Urol 2016;70(1):21–30. doi: 10.1016/j.eururo.2015.11.010.
  11. Heidenreich A., Pfister D., Porres D. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study. J Urol 2015;193(3):832–8. doi: 10.1016/j.juro.2014.09.089
  12. Takakusagi Y., Koge H., Kano K. et al. Safety of carbon-ion radiotherapy for prostate cancer after rectal cancer surgery. Anticancer Res 2023;43(6):2691–5. doi: 10.21873/anticanres.16435
  13. Luciani L.G., Mattevi D., Puglisi M. et al. Robotic-assisted radical prostatectomy following colo-rectal surgery: a user’s guide. J Robotic Surg 2022;16(1):189–92. doi: 10.1007/s11701-021-01228-1
  14. Brière R., Martin AG., Letarte F. et al. Surgical management of rectal cancer with synchronous treatment of prostate cancer. Langenbecks Arch Surg 2024;409(1):133. doi: 10.1007/s00423-024-03327-7
  15. Guandalino M., Dupré A., François M.O. et al. Previous radiation for prostate neoplasm alters surgical and oncologic outcomes after rectal cancer surgery. J Surg Oncol 2015;112(8):802–8. doi: 10.1002/jso.24075
  16. Buscail E., Blondeau V., Adam J.‐P. et al. Surgery for rectal cancer after high‐dose radiotherapy for prostate cancer: is sphincter preservation relevant? Colorectal Dis 2015;17(11):973–9. doi: 10.1111/codi.12962
  17. Sverrisson I., Folkvaljon F., Chabok A. et al. Anastomotic leakage after anterior resection in patients with rectal cancer previously irradiated for prostate cancer. Eur J Surg Oncol 2019;45(3):341–6. doi: 10.1016/j.ejso.2018.11.015
  18. Sverrisson I., Smedh K., Chabok A., Nikberg M. The risk for rectal cancer recurrence and overall mortality is not increased in men previously diagnosed with prostate cancer: a report from the Swedish colorectal cancer registry. Int J Colorectal Dis 2024;39(1):137. doi: 10.1007/s00384-024-04710-y
  19. Семенов В.В., Курыгин А.А. Симультанные операции на органах живота: спорные и очевидные аспекты проблемы. Вестник хирургии имени И.И. Грекова 2014;173(6):96–9. doi: 10.24884/0042-4625-2014-173-6-96-99 Semenov V.V., Kurygin A.A. Simultaneous operations on abdominal organs: controversial and obvious aspects of the problem. Vestnik khirurgii imeni I.I. Grekova = I.I. Grekov Surgery Bulletin 2014;173(6):96–9. (In Russ.). doi: 10.24884/0042-4625-2014-173-6-96-99
  20. Воскресенский А.А., Герасимовский Н.В. Опыт симультанных операций при синхронном раке прямой кишки и предстательной железы: серия клинических случаев. Хирургия и онкология 2025;15(4):87–91. doi: 10.17650/2949-5857-2025-15-4-87-91 Voskresenskiy A.A., Gerasimovskiy N.V. Simultaneous surgeries in synchronous rectal and prostate cancers: case series. Khirurgiya i onkologiya = Surgery and Oncology 2025;15(4):87–91. (In Russ.). doi: 10.17650/2949-5857-2025-15-4-87-91
  21. Platt E., Dovell G., Smolarek S. Systematic review of outcomes following pelvic exenteration for the treatment of locally advanced rectal cancer. Tech Coloproctol 2018;22(11):835–45. doi: 10.1007/s10151-018-1883-1
  22. Yaxley J.W., Coughlin G.D., Chambers S.K. et al. Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. Lancet 2016;388(10049):1057–66. doi: 10.1016/S0140-6736(16)30592-X
  23. Fukata K., Akiyoshi T., Numao N. et al. Robotic-assisted laparoscopic surgery for synchronous primary rectal and prostate cancer: initial case series. Asian J Endosc Surg 2022;15(3):678–82. doi: 10.1111/ases.13048
  24. Williams M., Perera M., Nouhaud F.X. et al. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy. Investig Clin Urol 2021;62(1):111–20. doi: 10.4111/icu.20200176
  25. Imagami T., Takayama S., Hattori T. et al. Combined laparoscopic and robotic surgery for synchronous colorectal and genitourinary cancer: a case series. Int J Surg Case Rep 2018;51:323–7. doi: 10.1016/j.ijscr.2018.09.021
  26. Collin H., Huang B., Siriwardana A. et al. Simultaneous robotic-assisted prostatectomy and rectal resection: a systematic review. J Robot Surg 2025;19(1):229. doi: 10.1007/s11701-025-02395-1
  27. Sugihara K., Kobayashi H., Kato T. et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 2006;49(11):1663–72. doi: 10.1007/s10350-006-0714-z
  28. Taylor F.G., Quirke P., Heald R.J. et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol 2014;32(1):34–43. doi: 10.1200/JCO.2012.45.3258
  29. Akiyoshi T., Ueno M., Matsueda K. et al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 2014;21(1):189–96. doi: 10.1245/s10434-013-3216-y
  30. Cheung D.C., Fleshner N., Sengupta S. et al. A narrative review of pelvic lymph node dissection in prostate cancer. Transl Androl Urol 2020;9(6):3049–57. doi: 10.21037/tau-20-729
  31. Царьков П.В., Бабаджанян А.Р., Тулина И.А. и др. Факторы риска поражения латеральных тазовых лимфоузлов при раке прямой кишки. Вестник Национального медико-хирургического Центра им. Н.И. Пирогова 2021;16(1):57–61. doi: 10.25881/BPNMSC.2021.97.93.010 Tsarkov P.V., Babadzhanyan A.R., Tulina I.A. et al. Risk factors for lateral pelvic lymph node involvement in rectal cancer. Vestnik Natsional’nogo mediko-khirurgicheskogo Centra im. N.I. Pirogova = Bulletin of the N.I. Pirogov National Medical and Surgical Center 2021;16(1):57–61. (In Russ.). doi: 10.25881/BPNMSC.2021.97.93.010
  32. Yokoyama Y., Nozawa H., Sasaki K. et al. Essential anatomy for lateral lymph node dissection. Ann Coloproctol 2023;39(6):457–66. doi: 10.3393/ac.2023.00164.0023
  33. Maderthaner L., Furrer M.A., Studer U.E. et al. More extended lymph node dissection template at radical prostatectomy detects metastases in the common iliac region and in the fossa of Marcille. BJU Int 2018;121(5):725–31. doi: 10.1111/bju.13993
  34. Hazen S.J.A., Sluckin T.C., Konishi T. et al. Lateral lymph node dissection in rectal cancer: state of the art review. Eur J Surg Oncol 2022;48(11):2315–22. doi: 10.1016/j.ejso.2021.11.003
  35. Tsarkov P., Balaban V., Babajanyan A. et al. Lateral pelvic lymph node positivity (LPLNP) score: predictive clinic-radiological model of lateral pelvic lymph node involvement in rectal cancer patients. Int J Colorectal Dis 2024;39(1):145. doi: 10.1007/s00384-024-04717-5
  36. Petersen L.J., Zacho H.D. PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review. Cancer Imaging 2020;20(1):10. doi: 10.1186/s40644-020-0290-9
  37. Ishikawa T., Homma S., Nishikawa M. et al. Laparoscopic abdominoperineal resection with lateral lymph node dissection for advanced rectal and prostate cancer with synchronous lateral lymph node metastases. Asian J Endosc Surg 2019;12(1):118–21. doi: 10.1111/ases.12598
  38. Yaegashi M., Otsuka K., Nakamura Y. et al. Advanced synchronous rectal and prostate cancers diagnosed by lateral lymph node dissection: a case report. Int J Surg Case Rep 2021;88:106494. doi: 10.1016/j.ijscr.2021.106494

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2026 ABV-press

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77-85909 от  25.08.2023.